Evaluation of the RESTART Survival Programme
ConditionInvasive Breast Cancer
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-99
SponsorJules Bordet Institute
About this trial
The RESTART survivorship programme has been implemented in the care pathway for patients with localised breast cancer since 2022. In this project, investigators are going to evaluate the satisfaction of patients taking part in the RESTART programme, as well as measuring changes in quality of life and health literacy after participation in the RESTART programme.
Eligibility criteria
Qualifiers
Age >= 18 at the time of signing the ICF
Minimum understanding of French
Signed study informed consent form obtained prior to any study-related procedure.
Participation in the RESTART programme
Disqualifiers
None
Trial design
Treatments tested in this trial
- educational workshops
Treatment groups
No treatment groups listed
Locations
This trial has no locations
Sponsors and collaborators
Jules Bordet Institute
Lead sponsor
Source ClinicalTrials.gov